Thirty-two transplant recipients with cytomegalovirus (CMV) infection documented by
positive culture of blood and/or organs other than the liver were evaluated for hepatic …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

CYTOMEGALOVIRUS (CMV) INFECTION is transmitted by blood transfusion from
seropositive (CMV antibodypositive) donors and generally ranges in the normal host from …

As cytomegalovirus (CMV) disease was a leading cause of death following liver
transplantation in earlier reports, general CMV prophylaxis is widely used. We re‐evaluated …

Background Cytomegalovirus is a frequent cause of infection and morbidity after heart
transplantation, especially in patients treated with antilymphocytic drugs where the …

The use of postdetection antiviral treatment of cytomegalovirus (CMV) as a strategy to
prevent infection and disease in solid-organ transplant patients has not been evaluated by …

One hundred twenty-one adult liver transplant recipients were studied for the incidence, risk
factors, and morbidity associated with herpes viruses infections after transplantation. The …

The most common organ‐specific manifestation of cytomegalovirus (CMV) infection after
liver transplantation is hepatitis. Here we retrospectively describe the detailed virological …

Prospective studies of transfused immunocompetent patients in the 1960s and early 1970s
showed high rates of cytomegalovirus (CMV) infection, ranging from 16% to 67%. Similar …

For recipients of a solid organ transplant, cytomegalovirus infection causes many
pathological conditions including direct and indirect effects, most notably owing to the …